Mathematical Models of COVID-19 by Faria, Kate
Bridgewater State University 
Virtual Commons - Bridgewater State University 
Honors Program Theses and Projects Undergraduate Honors Program 
5-2021 
Mathematical Models of COVID-19 
Kate Faria 
Follow this and additional works at: https://vc.bridgew.edu/honors_proj 
 Part of the Biology Commons, Epidemiology Commons, Mathematics Commons, and the Virus 
Diseases Commons 
Recommended Citation 
Faria, Kate. (2021). Mathematical Models of COVID-19. In BSU Honors Program Theses and Projects. 
Item 470. Available at: https://vc.bridgew.edu/honors_proj/470 
Copyright © 2021 Kate Faria 
This item is available as part of Virtual Commons, the open-access institutional repository of Bridgewater State 
University, Bridgewater, Massachusetts. 
Mathematical Models of COVID-19
Kate Faria
Submitted in Partial Completion of the Requirements for




Dr. Nguyenho Ho, Thesis Advisor
Dr. Matthew Salomone, Committee Member
Dr. John Pike, Committee Member
Abstract
For more than a year, the COVID-19 pandemic has been a major public health issue, affecting
the lives of most people around the world. With both people’s health and the economy at great
risks, governments rushed to control the spread of the virus. Containment measures were heavily
enforced worldwide until a vaccine was developed and distributed. Although researchers today know
more about the characteristics of the virus, a lot of work still needs to be done in order to completely
remove the disease from the population. However, this is true for most of the infectious diseases
in existence, including Influenza, Dengue fever, Ebola, Malaria, and Zika virus. Understanding the
transmission process of a disease is usually acquired through biological and chemical studies. In
addition, mathematical models and computational simulations offer different approaches to predict
the number of infectious cases and identify the transmission patterns of a disease. Information
obtained helps provide effective vaccination interventions, quarantine and isolation strategies, and
treatment plans to reduce disease transmissions and prevent potential outbreaks. The focus of this
paper is to investigate the spread of COVID-19 and its effect on a population through mathematical
models. Specifically, we use SEIR and SEIR with vaccine models to formulate the spread of
COVID-19, where S, E, I, R, and V are susceptible, exposed, infected, recovered, and vaccinated
compartments, respectively. With these two models we calculate a central quantity in epidemiology
called the basic reproduction number, R0. This helps examine the dynamical behavior of the models
and how vaccines can help prevent the spread of the virus.
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The novel coronavirus (COVID-19) was initially identified in late December of 2019 in Wuhan,
China [11]. It is an infectious disease caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) [11]. With little information about this new virus, no known cure or effective
therapies, and an incubation period of approximately 14 days, the virus rapidly spread globally [29].
In fact, the long incubation period was not known at first. Also, there were many people that were
asymptomatic, unknowingly carrying and spreading the virus even though no symptoms were clearly
present. According to Carenzo et al., 40% of positive COVID-19 cases are from asymptomatic yet
infectious carriers [9]. In March of 2020, the World Health Organization declared COVID-19 a
pandemic [26, 37].
While COVID-19 can be deadly, symptoms, however, vary greatly from person to person [16].
While some may experience mild symptoms such as fever, coughing, and shortness of breath, others
may face more severe complications, including damage to the lungs, acute respiratory failure, or
sometimes even death [1, 32, 38]. Other symptoms may also include difficulty breathing, fatigue,
muscle or body aches, headaches, loss of taste or smell, sore throat, congestion, a runny nose, nausea
or vomiting, or diarrhea [16]. In addition, COVID-19 can have serious effects on anyone, but tends
to have more serious effects on older people or people with compromised immune systems. For older
adults, the seriousness of COVID-19 increases as age increases. The most at-risk age group is 85
years old and older [16]. For other older adults, the pattern is as follows: people in their 50s are
more at risk than people in their 40s, people in their 60s are more at risk than people in their 50s,
and so on [19].
COVID-19 also has similarities to the severe acute respiratory syndrome (SARS) of 2003 [53].
With SARS there were more than 8,000 cases and 774 deaths [53]. However, within 2 months
of the COVID-19 outbreak, there were more than 82,000 cases and more than 2,800 deaths [53].
Explanations for this include that Wuhan, the city that COVID-19 stemmed from, is the biggest
city in central China, which allowed for widespread exposure and therefore infections [53]. Another
explanation is that COVID-19 spread during the incubation period of the virus, when infectious
people were not yet showing symptoms, unlike SARS, where spreading occurred more often after
people had already developed symptoms [53]. A review in February of 2020 found that another
explanation is that COVID-19 has a higher transmissibility than SARS, as the average reproduction
number for COVID-19 was 3.28, higher than the reproduction number of SARS, which was 2.79
[53]. While COVID-19 has similarities to other upper-respiratory illnesses, it is unique in many
ways. COVID-19 shares many of the same symptoms of influenza [3]. However, some symptoms of
COVID-19 that are not symptoms of the flu or other respiratory viruses include a dry cough, the
loss of taste or smell, and blood clots in the veins and arteries of the lungs, heart, legs, and brain
[3]. In addition, while young children are a high-risk group for influenza and other upper-respiratory
illnesses, they are not a high-risk group for COVID-19, except for the complication of Multisystem
Inflammatory Syndrome [3].
At the beginning of the pandemic, the number of hospitalizations increased at an alarming level in
multiple regions of the world [30, 48, 8]. In Italy in March of 2020, the government released guidelines
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on how to ration hospital care [10]. In the United States, elective surgeries were postponed in an
effort to reduce Intensive Care Unit (ICU) overcapacity [48]. According to [48], the cancellation of
all elective surgeries allowed for the ICU overcapacity to decrease from 160% to 130%. COVID-19
also severely affected the economy with high unemployment rates and a decline in GDP across the
globe [32, 5, 12]
With both asymptomatic and symptomatic infectious carriers with a 14-day incubation period,
high transmission rate, and high numbers of fatalities, COVID-19 is deadly and extremely hard to
track and contain. To control the spread of the virus, governments worldwide started implementing
non-pharmaceutical interventions. These included temporary closures of schools and non-essential
businesses, the use of face masks, and social distancing while the world waited for a vaccine that
could be used to minimize the spread of the virus [13]. Although the spread of COVID-19 began to
slow as a result of these new containment measures, the fight against the virus was far from over.
Having a vaccine seems to be the only long-term solution that can stop the virus from devastating
people’s lives and the global economy further.
The detrimental effects and control measures of COVID-19 can be reduced only after enough
people in the population are immune to the disease. This is why the distribution of vaccines is so
critical. Vaccines teach the immune system how to fight COVID-19; thus, preventing an exposed
individual from developing the infection [21]. This in turn prevents the virus from spreading if an
unvaccinated individual comes into contact with the exposed but vaccinated individual, and is a
similar but even safer scenario when both individuals that are in contact are vaccinated [14].
Fortunately, by February of 2021, the FDA approved COVID-19 vaccines from three different
companies, including Pfizer-BioNTech, Moderna, and Johnson & Johnson [15]. The first approved
vaccine was the Pfizer-BioNTech COVID-19 Vaccine, authorized by the FDA on December 11, 2020
[20, 46]. This was the first emergency use authorization (EUA) for a vaccine [46]. The Pfizer vaccine
consists of 2 doses administered 21 days apart. It is safe for people ages 16 and older [20]. The
efficacy of the vaccine is 95% [20]. The second vaccine authorized by the FDA in another EUA was
the Moderna COVID-19 vaccine, authorized on December 18th, 2020 [18, 45]. The Moderna vaccine
also includes 2 doses, with doses separated by 28 days, and is for people ages 18 and older [18]. The
efficacy of the Moderna vaccine is 94.1% [18]. The third vaccine authorized by the FDA in another
EUA was the Janssen (Johnson & Johnson) COVID-19 vaccine, on February 27th, 2021 [17, 44].
This vaccine is a single dose and is safe for people ages 18 and older [17]. The efficacy of the Janssen
vaccine is 66.3%, which is underwhelming compared to Pfizer and Moderna vaccines [17].
According to the CDC, individuals are considered fully vaccinated two weeks after receiving the
final dose of the vaccine [22]. In addition, after vaccination, restrictions for those vaccinated are
slightly lifted [22]. People that are fully vaccinated can gather indoors with other fully vaccinated
people without having to wear face masks [22]. Vaccinated people can also gather indoors with one
household of unvaccinated people without wearing face masks, unless that household has a member
that is at an increased risk of severe illness from COVID-19 [22]. A vaccinated person that comes
into contact with someone that has COVID-19 does not need to quarantine or get tested unless the
vaccinated person develops symptoms, or does not develop symptoms but lives in a group setting
[22]. Vaccines are the answer for keeping people the safest and allowing a return back to normal life.
Researchers from fields such as epidemiology, genetics, and related fields have been working
diligently since the disease outbreak to gain a thorough understanding of the virus’s mechanism
[40, 33, 31]. This helps medical teams understand how the virus spreads biologically, which can
lead to the development of viable therapeutic treatments such as vaccines. On the other hand,
mathematical models have been shown to be effective methods for imparting knowledge about the
nature of infectious diseases. They also contribute insights to help develop optimal controls and
facilitate non-pharmaceutical interventions to minimize the spread of a virus [6]. In other words,
through epidemiological models we are able to get a better understanding of the disease, how it
works, how to contain it, and how it can be cured. In fact, since the outbreak of COVID-19,
numerous mathematical studies have been carried out and provided predictions of the spreading of
COVID-19 [36]. A summary of various mathematical models used in studies of COVID-19 is shown
in Table (1.1)
In this research, a deterministic SEIR model is examined. Here, S, E, I, and R are susceptible,
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Models References
SIR [4, 23, 54, 27]
SEIR [55, 42, 41, 43]
SIQR [25, 39, 47]
SEIQR [52, 56]
Table 1.1: Summary of different mathematical models used in studies of COVID-19
exposed, infected, and recovered compartments, respectively. We also consider an SEIR model
with a vaccine compartment. The basic reproduction number of each model is calculated using the
next-generation matrix technique. Comparison of the two models show the effect on the population
when a vaccine is introduced. In addition, positivity and boundedness of the solutions, equilibrium
points and their stability are also inspected.
Chapter 2
The Basic Reproduction Number,
R0
2.1 Definition
The basic reproduction number, denoted as R0, is defined as the average number of secondary
infections caused by a single infectious individual introduced into a completely susceptible population
[24, 49]. This number is a central quantity in investigating a disease outbreak. There are two main
scenarios that can occur in a population where a disease is present. If the basic reproduction number
is less than one, the disease eventually vanishes from the population. If it exceeds one, an epidemic
likely occurs [24, 49, 27]. For instance, when R0 = 2, one infectious person can transmit the disease
to two other individuals. Thus, it is important and essential to determine and analyze R0 of an
infectious disease. Mathematically, the basic reproduction number can be obtained using the next-
generation matrix method [24, 35, 7]. The mathematical backgrounds required for the method are
presented in the next section.
2.2 Mathematical Backgrounds
Definition 2.2.1 (Spectral radius). [35] The spectral radius of a matrix A is defined as the maximum
of the absolute values of the eigenvalues of A:
ρ(A) = sup{| λ |: λ ∈ σ(A)},
where σ(A) denotes the set of eigenvalues of A.
Definition 2.2.2 (Nonnegative matrix). [51] A matrix A = [aij ] is nonnegative if aij ≥ 0. The
matrix A is a positive matrix if aij > 0.
Definition 2.2.3 (Irreducible nonnegative matrix). [34] A nonnegative matrix A is irreducible if it







where A11 and A22 are nontrivial square block matrices and P is a permutation matrix.
Definition 2.2.4 (Z sign pattern). [50] A matrix B = [bij ] has the Z sign pattern if bij ≤ 0 for all
i 6= j.
Definition 2.2.5 (M-matrix). [35] A matrix A is called an M-matrix if:
• A has the Z-pattern, that is, the off-diagonal elements of A are nonpositive.
7
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• The inverse of A exists and has nonnegative elements: A−1 ≥ 0.
Definition 2.2.6 (Singular and nonsingular matrix). [51] An n×n matrix A is called nonsingular
or invertible if there exists an n× n matrix B such that
AB = In = BA,
where In is the n × n identity matrix. Any matrix B that has the above property is the inverse of
A. If A does not have an inverse, then A is called singular.
Theorem 2.2.1 (The Perron-Frobenius Theorem). [34] Let P be an irreducible nonnegative matrix.
Then,
(a) The spectral radius ρ(P ) of P is positive and it is an algebraically simple eigenvalue of P with
corresponding left and right positive eigenvector, which are unique up to scalar multiples.
(b) The spectral radius of P is the unique eigenvalue with a nonnegative eigenvector.
(c) The spectral radius of the matrix P increases (strictly), resp. decreases, if any entry of it in-
creases, resp. decreases.
The proof of Theorem 2.2.1 can be found in [34].
Lemma 2.2.1. [7] If A has the Z sign pattern, then A−1 ≥ 0 if and only if A is a nonsingular
M-matrix.
Lemma 2.2.2. [7] If F is nonnegative and V is a nonsingular M-matrix, then R0 = ρ(FV −1) < 1
if and only if all eigenvalues of (F-V) have negative real parts.
Proof : Suppose F ≥ 0 and V is a nonsingular M-matrix. By Lemma 2.2.1 , V −1 ≥ 0. Thus,
(I−FV −1) has the Z sign pattern, and by Lemma 2.2.1, (I−FV −1)−1 ≥ 0 if and only if ρ(FV −1) <
1. From the equalities (V −F )−1 = V −1(I−FV −1)−1 and V (V −F )−1 = I+F (V −F )−1, it follows
that (V − F )−1 ≥ 0 if and only if (I − FV −1)−1 ≥ 0. Finally, (V -F ) has the Z sign pattern, so by
Lemma 2.2.1, (V −F )−1 ≥ 0 if and only if (V −F ) is a nonsingular M-matrix. Since the eigenvalues
of a nonsingular M-matrix all have positive real parts, this completes the proof. 
2.3 The Next-Generation Matrix Method
In this section we present the method of the next-generation matrix to calculate the basic re-
production number of ordinary differential equation compartmental models for disease transmission
[35, 7, 2]. The method was first proposed by Diekmann et al. in [28] and was later expanded by
Driessche et al. in [50]. Here, we provide an outline of the next-generation matrix method.
We divide the compartments of an epidemiological model into two broad categories: infected
compartments and noninfected (healthy) compartments. Specifically, a compartment is called an
infected compartment if the individuals in that compartment are infectious. Compartments
where individuals are infected but not infectious (such as latent individuals) are also among the
infected compartments. The remaining compartments in which the individuals are not infectious
are the noninfected compartments. We assume that there are n infected compartments and m
noninfected compartments, so the entire ordinary differential equation model has m+ n dependent
variables. Let x be the vector of dependent variables in the infected compartments, and let y be the
vector of variables in the noninfected compartments. We have x ∈ Rn and y ∈ Rm.
(1) First, we arrange the equations so that the first n components of the ordinary differential equa-
tion (ODE) system correspond to the infected compartments. Thus, we write the original ODE
system as
x′i = fi(x, y), i = 1, ..., n,
y′j = gj(x, y), j = 1, ...,m.
Kate Faria Mathematical Models of COVID–19 9
(2) Second, we partition the right-hand side in the infected compartments in the following way:
x′i = Fi(x, y)−Vi(x, y), i = 1, ..., n, (2.1)
y′j = gj(x, y), j = 1, ...,m,
where
• Fi is the rate of appearance of new infections in compartment i,
• Vi = V−i − V
+
i represents the difference between the rate of transfer of individuals out of
compartment i and the rate of transfer of individuals into compartment i. These include
transitional terms, such as births, deaths, disease progression, and recovery.
A visual representation of the partition (2.1) is shown in Fig.(2.1).
Figure 2.1: Fluxes entering and leaving compartment i
We note that this decomposition in infected and noninfected compartments as well as the de-
composition into F and V may not be unique. Different decompositions may result in different
interpretations of the disease process and may lead to somewhat different expressions of the
reproduction number. The decomposition should satisfy the following properties:
• Fi(0, y) = 0 and Vi(0, y) = 0 for y ≥ 0 and i = 1, ..., n. The first condition says that all
new infections are secondary infections arising from infectious hosts. The second condition
says that there is no immigration of susceptible individuals into the disease compartments.
• Fi(x, y) ≥ 0 for all x, y ≥ 0.
• Vi(x, y) ≤ 0 whenever xi = 0, for i = 1, ..., n. Each component Vi represents the net outflow





Vi(x, y) ≥ 0 for all x, y ≥ 0. The total outflow of all infected compartments is positive.
(3) Assume that the disease-free system
y′ = g(0, y),
has a unique disease-free equilibrium E0 = (0, y0) such that all solutions with initial conditions
of the form (0, y) approach (0, y0) as t →∞. Determine the disease-free equilibrium E0.












These matrices appear from the linearization of the system (2.1) around the disease-free equi-
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for every pair (i, j). This implies that the linearized equations for the infected compartments
x evaluated at the disease-free equilibrium are decoupled from the remaining equations. The
linearized system for the infected compartments can be written as
x′ = (F − V )x,
where the F and V matrices are defined above.
(5) The next-generation matrix is defined as FV −1 and the basic reproduction number is set to be
the dominant eigenvalue of FV −1, or R0 = ρ(FV −1).
2.3.1 The Main Theorem
Theorem 2.3.1. [7] Consider the disease transmission model given by (2.1). The disease-free
equilibrium of (2.1) is locally asymptotically stable if R0 < 1, but unstable if R0 > 1.
The proof of Theorem 2.3.1 is shown in Appendix 5.1. The above theorem can be summarized
by the following widely used theorem to analyze the stability of the disease-free equilibrium [35].
Theorem 2.3.2. A necessary and sufficient condition for an equilibrium to be locally asymptotically
stable is that all eigenvalues of the Jacobian have negative real part.
2.3.2 Example: An Influenza Model
To illustrate the power of the next-generation matrix introduced in the previous section, we
consider the following influenza model. In the model, we assume that there is an incubation period
between infection and appearance of symptoms. In addition, a significant fraction of people who
are infectious never develop symptoms but go through an asymptomatic period, during which they
have some infectivity, and then recover and go to the recovered compartment. And, there is a small
number I0 of initial infections. The model is described by the system of differential equations as [2]
dS
dt
= −βSI − βSδA,
dL
dt
= βSI + βSδA− κL,
dI
dt
= pκL− αI, (2.2)
dA
dt
= (1− p)κL− ηA,
dR
dt
= αI + ηA,
where S, L, I, A, and R are the susceptible, latent, infected, asymptomatic, and recovered com-
partments, respectively. The parameters in System (2.2) are detailed in Table (2.1). Next, we use
Parameters Description
β transmission rate
δ infectivity reduced factor
κ asymptomatic infectious rate
p fraction of latent members
η recovery rate of asymptomatic individuals
α recovery rate of infectious individuals
Table 2.1: Description of parameters of System (2.2)
the next-generation matrix method to determine the basic reproduction number of the model. Since
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the next-generation matrix focuses only on compartments containing new infections, we consider




= βSI + βSδA− κL,
dI
dt
= pκL− αI, (2.3)
dA
dt
= (1− p)κL− ηA.
For each differential equation in System (2.3), we partition the compartments into Fi and Vi, for
i = 1, 2, 3, as




V2 = −pκL+ αI,
V3 = −(1− p)κL+ ηA.


























































 κ 0 0−pκ α 0
−(1− p)κ 0 η
 .















Since FV −1 is an upper triangular matrix, the eigenvalues are the entries of the main diagonal







, λ2 = 0, λ3 = 0.
Thus, by the next-generation matrix method, the basic reproduction number is the dominant
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The reproduction number of the system (2.2) can be explained as follows: a susceptible person
becomes infectious with the probability p in which the asymptomatic individual causes βS0/α in-
fections during the infectious period of time 1/α, or the susceptible person becomes asymptomatic
with probability 1−p, in which the latent member causes δβS0/η infections during an asymptomatic





We consider the SEIR model to study the spread and the effects of COVID-19 on a population.
Here, S, E, I, and R represent the susceptible, exposed, infected, and recovered compartments,
respectively. The model is formulated based on the following assumptions.
3.1.1 Assumptions
(i) The size of the total population remains constant. That is, N = S(t) + E(t) + I(t) +R(t).
(ii) Susceptible individuals are recruited into the S compartment at a constant rate, Λ.
(iii) The transmission rate from an exposed person to a susceptible is β1 and the transmission rate
from an infectious person to a susceptible is β2. Here, we assume that β1 < β2. This means the
disease is more likely to spread from an infectious individual than from an exposed individual.
(iv) Individuals in the exposed (E) compartment have a short incubation period. Some become
infectious and move to the infected (I) compartment at the rate γ. Whereas, some recover and
move to the recovered (R) compartment at the rate σ.
(v) When becoming infectious, individuals can recover from the disease and move to the recovered
(R) compartment at the rate κ. In contrast, some perish by the disease at the rate δ.
(vi) Recoveries are assumed to be permanent.
(vii) Natural mortality occurs in all compartments at the rate µ.
(viii) All parameters in the model are positive.




= Λ− β1S(t)E(t)− β2S(t)I(t)− µS(t),
dE
dt
= β1S(t)E(t) + β2S(t)I(t)− γE(t)− σE(t)− µE(t), (3.1)
dI
dt
= γE(t)− κI(t)− δI(t)− µI(t),
dR
dt
= σE(t) + κI(t)− µR(t).
13
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A visual representation of System (3.1) is shown in Figure (3.1).
Figure 3.1: The diagram of System (3.1)
In addition, the parameters in the model are summarized in Table (3.1).
Parameters Description
Λ recruitment rate
β1 rate of contraction of susceptible from exposed
β2 rate of contraction of susceptible from infectious
γ rate at which an exposed individual becomes infectious
σ rate at which an exposed person recovers from the disease
κ rate at which an infectious individual recovers from the disease
δ disease-induced death rate due to infected class
µ natural death rate
Table 3.1: Description of parameters of system (3.1)
3.2 Mathematical Model Analysis
In this section we focus on the analysis of the model, including the positivity and boundedness of
the solutions, the basic reproduction number, and the different equilibrium points and their stability.
3.2.1 Positivity and Boundedness of Solutions
Theorem 3.2.1. Given the initial conditions {S(0) ≥ 0, E(0) ≥ 0, I(0) ≥ 0, R(0) ≥ 0}, the solution
set {S(t), E(t), I(t), R(t)} is positive whenever the parameters are nonnegative.
Proof : The proof of the theorem proceeds as follows: for dS/dt,
dS
dt
= Λ− β1S(t)E(t)− β2S(t)I(t)− µS(t),
= Λ− S(t)[β1E(t) + β2I(t) + µ],
dS
dt
≥ −S(t)[β1E(t) + β2I(t) + µ].
We denote λ(t) = β1E(t) + β2I(t) + µ. Then, dS/dt becomes
dS
dt
≥ −S(t) · λ(t).
Kate Faria Mathematical Models of COVID–19 15
To determine the solution of the inequality we first find the solution of the equality version of






ln |S| = −
∫
λ(t)dt,








As S(0) ≥ 0 and the exponential function is always greater than zero, we obtain S(t) ≥ 0. Fol-
lowing a similar procedure we find that E(t), I(t), and R(t) are always nonnegative. The details of
the proofs for the positivity of E(t), I(t), and R(t) are shown in the Appendix 5.2. 




(S,E, I,R) ∈ R4+ :
Λ
δ + µ




where N(t) = S(t) + E(t) + I(t) +R(t).
















= Λ− δI(t)− µS(t)− µE(t)− µI(t)− µR(t),
= Λ− δI(t)− µ(S(t) + E(t) + I(t) +R(t)),
= Λ− δI(t)− µN(t).
Since I(t) ≤ N(t), or δI(t) ≤ δN(t), then dN/dt is bounded below by Λ− δN(t)− µN(t), or
Λ− δN(t)− µN(t) ≤ dN
dt
= Λ− δI(t)− µN(t).
On the other hand, in the case of no infections,
dN
dt
= Λ− δI(t)− µN(t) ≤ Λ− µN(t). Thus,
Λ− δN(t)− µN(t) ≤ dN
dt
≤ Λ− µN(t). (3.2)
Next, we show the boundedness of the solutions from the inequality (3.2). Using the integrating
















As t approaches ∞,
Λ
δ + µ
≤ N(t) ≤ Λ
µ
.
Thus, the solutions to the system are bounded within the invariant region Ω. 
3.2.2 Basic Reproduction Number




= β1S(t)E(t) + β2S(t)I(t)− γE(t)− σE(t)− µE(t),
dI
dt
= γE(t)− κI(t)− δI(t)− µI(t).
Kate Faria Mathematical Models of COVID–19 16
The equations can be written in the form of
dxi
dt
= Fi(x) − Vi(x) for i = 1, 2, where Fi(x) is
the rate of appearance of new infections in compartment i, and Vi(x) is the rate of other transitions
between compartment i and other infected compartments. Then,
F1 = β1S(t)E(t) + β2S(t)I(t),
F2 = 0,
and
V1 = γE(t) + σE(t) + µE(t),
V2 = −γE(t) + κI(t) + δI(t) + µI(t).










for i, j = 1, 2. Then, the





























































β1k1 S0 + β2γk1k2S0 β2k2 S0
0 0
 ,
where k1 = γ + σ + µ and k2 = κ+ δ + µ. Thus, FV
−1 is the next generation matrix and the basic















γ + σ + µ
· β1S0 +
γ
γ + σ + µ
· 1
κ+ δ + µ
· β2S0. (3.3)
Here, β1S
0 is the contraction rate of the virus of S0 susceptible individuals from an exposed
individual, and 1/(γ+σ+µ) is the meantime in compartment E. In addition, β2S
0 is the contraction
rate of the virus of S0 susceptibles from an infectious individual, γ/(γ + σ + µ) is the fraction
progressing from compartment E to I, and 1/(κ+ δ+ µ) is the meantime in compartment I. Thus,
the reproduction number, R0, in Eq.(3.3) is the expected number of secondary infections produced
in compartment E by an exposed person or an infectious individual.
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3.2.3 Equilibrium Points
Equilibria are points where the variables are constant in time [35]. They can be found by setting
each equation in System (3.1) to zero (e.g. dS/dt = 0, dE/dt = 0, dI/dt = 0, dR/dt = 0). That is,
Λ− β1S(t)E(t)− β2S(t)I(t)− µS(t) = 0,
β1S(t)E(t) + β2S(t)I(t)− k1E(t) = 0, (3.4)
γE(t)− k2I(t) = 0,
σE(t) + κI(t)− µR(t) = 0.
There are two types of equilibrium points: disease-free equilibrium and endemic equilibrium.
The calculation of each equilibrium is presented as follows.
Disease-free Equilibrium
The disease-free equilibrium (DFE) point is the steady-state solution of the system where no
disease is present in the population [35, 7]. That means no individuals are exposed or infected from
the disease; thus, no recoveries are necessary. We denote the DFE as E0 =
(
S0, E0, I0, R0
)
. For the
disease-free equilibrium (DFE), we set
I0 = 0, E0 = 0, R0 = 0. (3.5)
Then, only S0 needs to be found. Substituting (3.5) into System (3.4) yields
Λ− β1S0E0 − β2S0I0 − µS0 = 0,













The endemic equilibrium point, denoted as E∗ = (S∗, E∗, I∗, R∗), is the steady-state solution
where the disease persists in the population [35, 7]. For the endemic equilibrium we consider I∗ 6= 0,
E∗ 6= 0, and R∗ 6= 0. The solution of System (3.4) is
S∗ =
Λ


























(See Appendix 5.3 for the details of the derivations of the endemic equilibrium.)
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For simplification, the endemic equilibrium point can be written in terms of the basic reproduction







































This shows that the endemic equilibrium point exists only when R0 > 1. When R0 < 1, the
equilibrium becomes biologically irrelevant.
3.2.4 Stability Analysis
Theorem 3.2.3. The disease-free equilibrium E0 =
(






, 0, 0, 0
)
is locally asymptoti-
cally stable if R0 < 1 and is unstable if R0 > 1.
Proof : To prove that the disease-free equilibrium is asymptotically stable we need to show that
the eigenvalues of the Jacobian matrix, J , of the system (3.1) evaluated at the DFE are all negatives.
The eigenvalues can be obtained by solving the characteristic equation |J − λI| = 0. That is,
|J − λI| =

−µ− λ −β1S0 −β2S0 0
0 β1S
0 − k1 − λ β2S0 0
0 γ −k2 − λ 0
0 σ κ −µ− λ
 ,
= (−µ− λ)
β1S0 − k1 − λ β2S0 0γ −k2 − λ 0
σ κ −µ− λ
 ,
= (−µ− λ)(−µ− λ)
[
β1S
0 − k1 − λ β2S0






0 − k1 − λ
)
(−k2 − λ)− β2S0γ
]
= 0.
From here, we are able to obtain one eigenvalue, namely, λ = −µ < 0. Next, we need to show
that the eigenvalues obtained from
(
β1S
0 − k1 − λ
)
(−k2 − λ)− β2S0γ = 0 are also negative.(
β1S
0 − k1 − λ
)
(−k2 − λ)− β2S0γ = 0,
λ2 + λk2 + λk1k2 − β1S0λ− β1S0k2 − β2S0γ = 0,
λ2 + λ
(
k1 + k2 − β1S0
)
+ k1k2 − β1S0k2 − β2S0γ = 0.











(k1 + k2 − β1S0)2 − 4 (k1k2 − β1S0k2 − β2S0γ)
]
.
Kate Faria Mathematical Models of COVID–19 19
To ensure that there are real eigenvalues we need to show that ∆ ≥ 0. That is,
∆ =
(
k1 + k2 − β1S0
)2 − 4 (k1k2 − β1S0k2 − β2S0γ) ,
= (k1 + k2)




)2 − 4k1k2 + 4 (β1S0k2 + β2S0γ) ,
= k21 + 2k1k2 + k
2




)2 − 4k1k2 + 4β1S0k2 + 4β2S0γ,




















Since all the parameters are assumed to be positive, this shows that the eigenvalues are distinct
real eigenvalues. We denote
λ1 = −
(















k1 + k2 − β1S0
)2 − 4 (k1k2 − β1S0k2 − β2S0γ) . Next, we show that λ1 and λ2 are
negative eigenvalues when R0 < 1. Suppose that λ1 < 0 we have
−
(




(k1 + k2 − β1S0)2 − 4 (k1k2 − β1S0k2 − β2S0γ) < 0,√
(k1 + k2 − β1S0)2 − 4 (k1k2 − β1S0k2 − β2S0γ) <
(
k1 + k2 − β1S0
)
,(
k1 + k2 − β1S0
)2 − 4 (k1k2 − β1S0k2 − β2S0γ) < (k1 + k2 − β1S0)2 ,
−4
(
k1k2 − β1S0k2 − β2S0γ
)
< 0,









Using a similar approach we can show that λ2 < 0 when R0 < 1. Then, by Theorem 2.3.1 the DFE
E0 is locally asymptotically stable. On the other hand, if we assume that λ1 > 0, then
−
(




(k1 + k2 − β1S0)2 − 4 (k1k2 − β1S0k2 − β2S0γ) > 0,√
(k1 + k2 − β1S0)2 − 4 (k1k2 − β1S0k2 − β2S0γ) >
(
k1 + k2 − β1S0
)
,(
k1 + k2 − β1S0
)2 − 4 (k1k2 − β1S0k2 − β2S0γ) > (k1 + k2 − β1S0)2 ,
−4
(
k1k2 − β1S0k2 − β2S0γ
)
> 0,









Then, by Theorem 2.3.1 the DFE is unstable when R0 > 1. 
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3.3 SEIR Model with Vaccine Compartment
Next, we consider a mathematical model where a vaccine compartment is added into the original
SEIR model.
3.3.1 Assumptions
To build an SEIR model with a vaccine compartment we use the same assumptions as in Section
3.1.1. In addition, we consider a hypothetical imperfect COVID-19 vaccine. That means the virus
can still be transmissible to vaccinated individuals with a reduced rate of (1−εv)β1 from an exposed




= Λ− ηS(t)− β1S(t)E(t)− β2S(t)I(t)− µS(t),
dV
dt
= ηS(t)− (1− εv)β1V (t)E(t)− (1− εv)β2V (t)I(t)− µV (t), (3.6)
dE
dt
= β1S(t)E(t) + β2S(t)I(t) + (1− εv)β1V (t)E(t) + (1− εv)β2V (t)I(t)− γE(t)− σE(t)− µE(t),
dI
dt
= γE(t)− κI(t)− δI(t)− µI(t),
dR
dt
= σE(t) + κI(t)− µR(t).
The diagram of the SEIR with vaccine is shown in Figure (3.2).
Figure 3.2: The diagram of System (3.6)
A summary of the parameters in System (3.6) is shown in Table (3.2).
3.3.2 Basic Reproduction Number




= β1S(t)E(t) + β2S(t)I(t) + (1− εv)β1V (t)E(t) + (1− εv)β2V (t)I(t)− γE(t)− σE(t)− µE(t),
dI
dt
= γE(t)− κI(t)− δI(t)− µI(t).
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Parameters Description
Λ recruitment rate
β1 rate of contraction of susceptible from exposed
β2 rate of contraction of susceptible from infectious
γ rate at which an exposed individual becomes infectious
σ rate at which an exposed individual recovers
κ rate at which an infectious individual recovers
δ disease-induced death rate
µ natural death rate
εv vaccine efficacy against acquisition of infection (degree of protection)
η vaccination rate
Table 3.2: Description of parameters of System (3.6)
Then,
F1 = β1S(t)E(t) + β2S(t)I(t) + (1− εv)β1V (t)E(t) + (1− εv)β2V (t)I(t),
F2 = 0,
V1 = γE(t) + σE(t) + µE(t),
V2 = −γE(t) + κI(t) + δI(t) + µI(t).
























 = [γ + σ + µ 0

































 (β1S0v + (1− εv)β1V 0)k2 + (β2S0v + (1− εv)β2V 0)γk1k2 (β2S
0




The basic reproduction number is the dominant eigenvalue of the matrix FV −1. Since the matrix
FV −1 is an upper triangular matrix, the eigenvalues are the entries on the main diagonal. Thus,




















γ + σ + µ
· β1S0v +
γ
γ + σ + µ
· 1






γ + σ + µ
· (1− εv)β1V 0 +
γ
γ + σ + µ
· 1
κ+ µ+ δ
· (1− εv)β2V 0.
Here, β1S
0
v is the rate of contraction of the virus of S
0
v susceptible individuals from exposed
individuals, (1 − εv)β1V 0 is the rate of contraction of the virus of V 0 vaccinated individuals from
exposed individuals, and
1
γ + σ + µ
is the meantime in compartment E. Also, β2S
0
v is the rate
of contraction of the virus of S0v susceptible individuals from infectious individuals, (1 − εv)β2V 0
is the rate of contraction of the virus of V 0 vaccinated individuals from infectious individuals,
γ
γ + σ + µ
is the progression from compartment E to compartment I, and
1
κ+ δ + µ
is the meantime
in compartment I. Thus, the reproduction number Rv0 in Eq. (3.6) is the expected number of
secondary infections produced in compartment E by an exposed or infectious individual.
3.3.3 Disease-free Equilibrium of the Vaccine Model
The basic reproduction number of the vaccine model is estimated based on the disease-free
equilibrium (DFE), denoted as E0v = (S0v , V 0, E0v , I0v , R0v). To determine the solutions we set each
equation of System (3.6) equal to zero. In other words,
Λ− ηS(t)− β1S(t)E(t)− β2S(t)I(t)− µS(t) = 0,
ηS(t)− (1− εv)β1V (t)E(t)− (1− εv)β2V (t)I(t)− µV (t) = 0,
β1S(t)E(t) + β2S(t)I(t) + (1− εv)β1V (t)E(t) + (1− εv)β2V (t)I(t)− γE(t)− σE(t)− µE(t) = 0,
γE(t)− κI(t)− δI(t)− µI(t) = 0,
σE(t) + κI(t)− µR(t) = 0.
Since there is no disease present in the population, we set E0v = 0, I
0
v = 0, and R
0
























COVID-19 was first identified in December 2019. Since then it has had detrimental impacts on
many factors of life globally. Many lives were lost and the economy plummeted. The implementation
of government control measures helped to slow the spread of the virus, but the real breakthrough
was in the development of multiple vaccines. The aim of the research is to obtain a theoretical result
on the impact of a vaccine in slowing the spread of the virus through epidemiology. In fact, we use an
SEIR deterministic compartment model to analyze the spread of the virus. Additionally, a vaccine
compartment is added into the SEIR model (e.g. SEIR with vaccine model) with the hypothesis
that the vaccine is imperfect to see how a vaccine would change the dynamics of the whole system.
We see improvement in lowering the number of cases of COVID-19 when people are vaccinated.
In fact, it is clear that the susceptible individuals of the SEIR model, S0 =
Λ
µ




. In other words, susceptibles that are vaccinated are assumed to move to the vaccine
compartment. Although vaccinated individuals are still able to contract the virus, they occur at
reduced rates of (1− εv)β1 and (1− εv)β2. This shows it is less likely for the vaccinated individuals
to be infected. Thus, it helps lower the number of cases moving from the S compartment to the E
compartment and potentially becoming infectious.
To further see the effect of vaccines we calculate the basic reproduction number for each model
using the next-generation matrix technique. The basic reproduction number of the SEIR model
(R0) and the SEIR with vaccine model (Rv0) are shown in Eq. (3.3) and Eq. (3.7), respectively. It
is important to obtain the basic reproduction number since it represents the number of individuals
the virus can spread to in a susceptible population from one infectious individual.
There are some similarities between the forms of the two basic reproduction numbers. Both
reproduction numbers have the same infection rates of a susceptible individual contracting the virus
from an exposed individual and of a susceptible individual contracting the virus from an infectious
individual. They also contain the same meantimes in compartments E and I, and the same rates of
progression from compartment E to compartment I.
The differences occur in the application of these rates and meantimes to the different compart-




0 , the latters whose sum
represents Rv0. The main difference between R0 and RV
0
0 is that RV
0
0 represents the implementation




0 is more similar to R0 because the rates and meantimes are applied to the susceptible
compartments of each model, the differences lie in the susceptible compartments themselves. S0v is
comprised of S0 with the addition of η, the vaccination rate, in the denominator. This makes S0v
smaller than S0, and combined with a similar situation in V 0, explains why RV 00 is smaller than R0.
Since the rate of infection decreases with the vaccine, the reproduction number also decreases. Thus,
with the availability of vaccines, fewer individuals will get the virus from one infectious individual.
The implementation of a vaccine reduces the number of infections and minimizes fatalities. Thus,
the more people who are vaccinated, the lower the number of infections and potential deaths. Al-
23
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though lockdowns and other interventions such as social distancing and face masks were shown to
help reduce COVID-19 infections, the addition of a vaccine reduced infections and deaths even more.
In an imperfect vaccine scenario like the one presented in this paper, the vaccine efficacy (εv) is
not 100%. This is a realistic model reflecting the vaccines that are available today. For example, in
America, the vaccines available include Pfizer, with 95% efficacy, Moderna, with 94.1% efficacy, and
Johnson & Johnson, with 66.3% efficacy. In an expansion of our work, we can implement the different
percentages into the model to compare the reproduction numbers. However, in a perfect vaccine
scenario, the efficacy of a perfect vaccine is 100%. That means once an individual is vaccinated,
they are immune to the disease, and thus cannot contract the disease from an exposed or infectious
individual. The preliminary results show that the disease-free equilibrium points for both cases of
the imperfect vaccine and perfect vaccine are the same. The endemic equilibrium points are different.
However, they are rather lengthy and tedious to analyze, and are beyond the scope of the report.
Throughout our research we have looked at many theorems and epidemiological models in an
effort to get the best models and methods for understanding COVID-19 infections. For the possible
continuation of this research, we have planned what our future work might look like. This includes
work on the sensitivity analysis as well as the optimal control for each model presented in the prior
sections. Since the effect of the virus is different for different age groups, we would also want to create
a mathematical model with age-structure. For instance, we would consider different age-dependent
compartments, such as a juvenile compartment (from ages 0 - 17), adult compartment (from ages
18 - 64), and elderly compartment (from ages 65-onward). Another extension we might consider is
analyzing the minimum number of people that need to be vaccinated in a given population with
other containment methods to keep Rv0 < 1.
Chapter 5
Appendix
5.1 The Proof of Theorem 2.3.1
Proof : Let F and V be defined as above, and let J21 and J22 be the matrices of partial derivatives
of g with respect to x and y evaluated at the disease-free equilibrium. The Jacobian matrix for the
linearization of the system about the disease-free equilibrium has the block structure
J =
[




The disease-free equilibrium is locally asymptotically stable if the eigenvalues of the Jacobian
matrix all have negative real parts. Since the eigenvalues of J are those of (F −V ) and J22, and the
latter all have negative real parts by assumption, the disease-free equilibrium is locally asymptoti-
cally stable if all eigenvalues of (F −V ) have negative real parts. By the assumptions on F and V, F
is nonnegative and V is a nonsingular M-matrix. Hence, by Lemma 2.2.2 all eigenvalues of (F − V )
have negative real parts if and only if ρ(FV −1) < 1. It follows that the disease-free equilibrium is
locally asymptotically stable if R0 = ρ(FV −1) < 1.
Instability for R0 > 1 can be established by a continuity argument. If R0 ≤ 1 then for any
ε > 0, ((1 + ε)I −FV −1) is a nonsingular M-matrix and by Lemma 2.2.1, ((1 + ε)I −FV −1)−1 ≥ 0.
By Lemma 2.2.2, all eigenvalues of ((1 + ε)V − F ) have positive real parts. Since ε > 0 is arbitrary,
and eigenvalues are continuous functions of the entries of the matrix, it follows that all eigenvalues
of (V − F ) have nonnegative real parts. To reverse the argument, suppose all the eigenvalues of
(V −F ) have nonnegative real parts. For any positive ε, (V +εI−F ) is a nonsingular M-matrix, and
by Lemma 2.2.2, ρ(F (V + εI)−1) < 1. Again, since ε > 0 is arbitrary, it follows that ρ(FV −1) ≤ 1.
Thus, (F − V ) has at least one eigenvalue with positive real part if and only if ρ(FV −1) > 1, and
the disease-free equilibrium is unstable whenever R0 > 1. 
Further discussions of the theorem can be found in [35, 6, 7].
5.2 The Proof of Theorem 3.2.1 for E(t), I(t), and R(t)




= β1S(t)E(t) + β2S(t)I(t)− γE(t)− σE(t)− µE(t),
= β2S(t)I(t) + E(t)[β1S(t)− γ − σ − µ],
dE
dt
≥ E(t)[β1S(t)− γ − σ − µ].
25
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In addition, we denote λE(t) = β1S(t)− γ − σ − µ. Then, the inequality becomes
dE
dt
≥ E(t) · λ(t).

























= γE(t)− κI(t)− δI(t)− µI(t),
= γE(t)− I(t) (κ+ δ + µ) ,
dI
dt
≥ −I(t) (κ+ δ + µ) .













ln |I| = −
∫
λIdt,






Finally, for R(t) we consider
dR
dt

















ln |R| = −
∫
λRdt,
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5.3 Endemic Equilibrium of SEIR Model
First, we solve dS/dt = 0 as









β1E∗ + β2I∗ + µ
. (5.1)
Next, we solve for dE/dt = 0 as
β1S
∗E∗ + β2S
∗I∗ − k1E∗ = 0,
S∗(β1E
∗ + β2I





























∗ − Λβ1E∗ − Λβ2I∗ = 0. (5.3)
But, from dI/dt = 0 we obtain
γ
k2


























To easily analyze the endemic equilibrium we rewrite E∗ in terms of the basic reproduction
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Next, we substitute E∗ into
γ
k2
E∗ = I∗ and obtain
I∗ =
γ
κ+ δ + µ
· Λ










(σE∗ + κI∗) .





















5.4 Endemic Equilibrium of SEIR Model with Vaccine Com-
partment
We use Mathematica to obtain the endemic equilibria of System (3.6). There are two endemic
equilibria and they are shown below.
It is obvious that the points are complicated and tedious to analyze. We hope this is part of the
future work that we can look more closely into.
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